Jean-Marc Plancher

This inventor holds 52 USPTO granted patents and 11 published patent applications, plus 4 CIPO patents and 26 EPO patents, primarily in Antiviral Compounds (CPC class C07D). Top assignees: Hoffmann-La Roche Inc., Other. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Marc Plancher. Retrieved from https://idiyas.com/inventor/jean-marc-plancher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52 (Patent Applications = 11)

% Patents Active = 21.2

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 26 (Patent Applications = 23)

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 81(Granted Patents)

Forward Citations (Not Self Cited) = 76(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Knoeringue, FR (2003 - 2009)
Basel, CH (2019)
Hagenthal-la-Bas, FR (2020)
Hagenthal le bas, FR (2007 - 2024)

Company Filing History:

51 out of 5,024

Hoffmann-La Roche Inc.

patents

1 out of 834,453

Other

patents

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

Arylsulfonamide Derivatives

Indolin-2-One Derivatives

Ethynyl Derivatives

Oxytocin Receptor Agonists

Antiviral Compounds

Triazole Boronic Acid Compounds

N-Heteroaryl Substituted Aniline

Pyrrolidine Derivatives

Benzimidazole Derivatives

Aminoindole Derivatives

Cyclopentane Derivatives

Tricyclic Amide Derivatives

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065399 - Arylsulfonamide derivatives (2024-08-20),

2. 11066393 - Indolin-2-one derivatives (2021-07-20),

3. 10710985 - Indolin-2-one derivatives (2020-07-14),

4. 10519140 - Indolin-2-one derivatives (2019-12-31),

5. 10457667 - Indolin-2-one derivatives (2019-10-29),

6. 10377746 - Indolin-2-one derivatives (2019-08-13),

7. 10065956 - Ethynyl derivatives (2018-09-04),

8. 10011607 - Ethynyl derivatives (2018-07-03),

9. 9751870 - Oxytocin receptor agonists for the treatment of CNS diseases (2017-09-05),

10. 9725416 - Ethynyl derivatives (2017-08-08),

11. 9693997 - Antiviral compounds (2017-07-04),

12. 9540345 - Antiviral compounds (2017-01-10),

13. 9464098 - Substituted triazole boronic acid compounds (2016-10-11),

14. 9382218 - N-heteroaryl substituted aniline derivatives as HCV-antivirals (2016-07-05),

15. 8524710 - Pyrrolidine derivatives (2013-09-03),

Title: Jean-Marc Plancher - Innovative Inventor from Hagenthal-le-Bas

Introduction: Jean-Marc Plancher is a renowned inventor hailing from Hagenthal-le-Bas, France, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Jean-Marc Plancher holds several patents in the areas of renewable energy, sustainable agriculture, and advanced materials, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Jean-Marc Plancher has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Jean-Marc Plancher has collaborated with top companies, innovative startups, and visionary inventors to bring his ideas to life and make a lasting impact on the world of innovation.

Conclusion: Jean-Marc Plancher's passion for pushing the boundaries of what is possible and his relentless pursuit of excellence make him a true pioneer in the world of inventions, inspiring the next generation of inventors to dream big and create a better future for all.

Profile summary based on public USPTO records.